Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.
Medtronic has had a poor quarter owing to the pandemic – but Zimmer’s has been even worse.
Sales of implants are set to fall sharply as non-urgent procedures are deferred.
The orthopaedics sector has seen several sizeable mergers over the past decade. Might it see more?
The UK ortho and woundcare group might yet pounce on Nuvasive.